Early Access Program From Roche for SMA Therapy Risdiplam in Europe - a podcast by SMA News Today

SMA News Today’s multimedia associate, Price Wooldridge, discusses an early access program from Roche for SMA therapy Risdiplam in Europe and forums Director Kevin Schaefer talks about forming friendships with his caregivers, and why he thinks this is important.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Further episodes of SMA News & Perspectives

Further podcasts by SMA News Today

Website of SMA News Today